EUVIMEDEUVIMED entdecken
Multizentrische StudieValidierungsstudieOpen Access · CC BY 4.0

Two-transcript signature for differentiation and clinical outcomes in severe fever with thrombocytopenia syndrome (SFTS) patients: a double-blind, multicenter, validation study

Nannan Xu, Sai Wen, Yongyuan Yao, Yanyan Guan, Lianhui Zhao, Lulu Yang, Hui Yang, Yishan He, Gang Wang iD

Journal of Clinical Microbiology · 2025

DOI: 10.1128/jcm.01282-24 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Clinical Microbiology, 2025. Verfasst von Nannan Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Severe Fever with Thrombocytopenia Syndrome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease with a high mortality rate that is often underdiagnosed due to the limitations of current laboratory testing. Timely diagnosis and early identification of severe cases are crucial to improving patient outcomes and overall survival rates. This study aimed to evaluate the efficacy of two transcripts, IFI44L and PI3, in the early differentiation between SFTS virus (SFTSV) infection and bacterial sepsis, as well as in the prompt identification of severe cases during epidemic seasons. In a prospective study conducted between 1 May 2021 and 30 September 2022, we enrolled 225 patients who presented with acute fever and thrombocytopenia at four hospitals in Shandong Province, China. The two-transcript signature provided a clear distinction between SFTS and bacterial infection, achieving an area under the receiver operating characteristic curve of 0.961 (95% confidence interval [95% CI] 0.916–0.986), outperforming C-reactive protein (0.810 [95% CI 0.738–0.870]) and procalcitonin (0.764 [95% CI 0.687–0.830]). Importantly, the relative expression of the IFI44L gene was significantly elevated in fatal SFTS cases, with an area under the curve (AUC) of 0.820 (95% CI 0.727–0.914), indicating its potential as an early prognostic marker. Additionally, IFI44L and PI3 were identified as potential biomarkers for distinguishing SFTS patients with and without invasive pulmonary aspergillosis, with AUC values of 0.817 and 0.753, respectively. Our findings demonstrate that the two-transcript signature effectively distinguishes SFTSV infection from bacterial sepsis and helps identify high-risk individuals, guiding appropriate treatment during SFTS outbreak.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Severe Fever with Thrombocytopenia SyndromeHumansMaleFemaleProspective StudiesMiddle AgedPhlebovirusAgedDouble-Blind MethodDiagnosis, DifferentialChinaROC CurveAdultBacterial Infections

Stichwörter der Autor:innen

diagnosishost transcriptsevere fever with thrombocytopenia syndromeseverity

Autor:innen und Institutionen

  • Department of Infectious Disease, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
  • Juxian People's Hospital, Rizhao, China.
  • Department of Infectious Disease, Rizhao People's Hospital, Rizhao, China.

ORCID-Profile: Gang Wang

Zitieren

APA

Xu, N., Wen, S., Yao, Y., Guan, Y., Zhao, L., Yang, L., Yang, H., He, Y., & Wang, G. (2025). Two-transcript signature for differentiation and clinical outcomes in severe fever with thrombocytopenia syndrome (SFTS) patients: a double-blind, multicenter, validation study. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01282-24

Vancouver

Xu N, Wen S, Yao Y, Guan Y, Zhao L, Yang L, et al. Two-transcript signature for differentiation and clinical outcomes in severe fever with thrombocytopenia syndrome (SFTS) patients: a double-blind, multicenter, validation study. Journal of Clinical Microbiology. 2025. doi:10.1128/jcm.01282-24

BibTeX
@article{Xu2025,
  author = {Xu, Nannan and Wen, Sai and Yao, Yongyuan and Guan, Yanyan and Zhao, Lianhui and Yang, Lulu and Yang, Hui and He, Yishan and Wang, Gang},
  title = {Two-transcript signature for differentiation and clinical outcomes in severe fever with thrombocytopenia syndrome (SFTS) patients: a double-blind, multicenter, validation study},
  journal = {Journal of Clinical Microbiology},
  year = {2025},
  doi = {10.1128/jcm.01282-24}
}
Kostenlos starten →